Sangita Shah
Corporate Officer/Principal bei PreEmptive Meds, Inc.
Vermögen: 62 118 $ am 30.04.2024
Profil
Sangita Shah currently works in finance and accounting at PreEmptive Meds, Inc. and currently holds a managerial position in the same field at the same company.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FORWARD INDUSTRIES INC.
1,10% | 22.12.2023 | 111 123 ( 1,10% ) | 62 118 $ | 30.04.2024 |
Aktive Positionen von Sangita Shah
| Unternehmen | Position | Beginn |
|---|---|---|
PreEmptive Meds, Inc.
 PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
PreEmptive Meds, Inc.
PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Health Technology |
